Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00891345
What this trial is testing

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

Who this might be right for
Hormone-refractory Prostate Cancer
CytoVac A/S 13
Testing effectiveness (Phase 2)Ended earlyNCT03853317
What this trial is testing

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc. 9
Not applicableUnknownNCT02420600
What this trial is testing

The Clinical Relevance of Immune Cells and CTC in HNSCC Patients

Who this might be right for
RecurrenceMetastasisDeath
Chang Gung Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00428714
What this trial is testing

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Who this might be right for
Prostate Cancer
Eli Lilly and Company 73
Early research (Phase 1)Active Not RecruitingNCT02065362
What this trial is testing

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Who this might be right for
EBV-positive Nasopharyngeal Carcinoma
Baylor College of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT02970981
What this trial is testing

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Who this might be right for
Melanoma
NYU Langone Health 18
Testing effectiveness (Phase 2)Study completedNCT00363051
What this trial is testing

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Who this might be right for
Islet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more
Novartis Pharmaceuticals 160
Not applicableLooking for participantsNCT05588154
What this trial is testing

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 1,000
Early research (Phase 1)Active Not RecruitingNCT05146739
What this trial is testing

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyMyelodysplastic Syndrome Post Cytotoxic TherapyMyeloid Leukemia Associated With Down Syndrome+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT02356445
What this trial is testing

Use of Immunosuppressive Therapy for Sarcoidosis

Who this might be right for
Sarcoidosis
University of Cincinnati 2,000
Not applicableUnknownNCT02630979
What this trial is testing

Oncologists Satisfaction With Outcomes of Some Cytotoxic Agents

Who this might be right for
Physician Satisfaction With the Outcomes of Cytotoxic Drugs
Ain Shams University 150
Testing effectiveness (Phase 2)Study completedNCT02661282
What this trial is testing

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Who this might be right for
Cytomegalovirus PositiveGlioblastomaGliosarcoma+3 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Testing effectiveness (Phase 2)Study completedNCT04967417
What this trial is testing

Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 13
Large-scale testing (Phase 3)Study completedNCT02551159
What this trial is testing

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 823
Early research (Phase 1)Study completedNCT00063648
What this trial is testing

Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant

Who this might be right for
Liver DiseaseLymphoproliferative Disorders
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Very early researchEnrolling By InvitationNCT06499025
What this trial is testing

Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)

Who this might be right for
AMLt(8;21)Neoantigen
BGI, China 16
Not applicableStudy completedNCT05939726
What this trial is testing

Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrodysesthesia

Who this might be right for
Palmar-Plantar ErythrodysesthesiaPalmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
Sarawak General Hospital 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT06762080
What this trial is testing

Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastasis
Guangzhou Medical University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07839819
What this trial is testing

Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies

Who this might be right for
Advanced Solid Tumor
PharmaMar 231
Next Page
8